Health
Public health, medicine, research institutes and the European agencies setting the standards.
Uzbekistan Builds Domestic Pediatric Surgery Hub, Curbing Costly Overseas Referrals
Uzbekistan has significantly expanded its domestic capacity for complex pediatric surgery, including liver and bone marrow transplants. The
Measles Cases Drop 75% in Europe, but Outbreak Risk Persists
Measles cases in Europe fell to 34,000 in 2025, a 75% drop from 2024. Despite this, the WHO warns that outbreaks remain likely due to insuff
Beyond the Podium: How Olympic Athletes Redefine Success and Build Resilience
US Olympic psychologists are shifting focus from medals to mental health, sleep, and process-oriented goals. Athletes like Paralympian Kenda
Greece Slashes ER Wait Times with QR-Coded Wristbands
Greece has reduced emergency care waiting times by implementing a QR-coded bracelet system in 10 hospitals. Average service time is now four
AI Breakthrough Uncovers First New Antibiotics in Decades to Combat MRSA
Researchers at MIT have identified the first new antibiotics in over 60 years using AI, targeting MRSA. The study, published in Nature, open
EU Targets 20% Cut in Antimicrobial Use to Combat Silent Pandemic
Antimicrobial resistance (AMR) causes 35,000 deaths yearly in the EU, with healthcare costs of €1.5 billion. The European Commission aims to
Antimicrobial Resistance: How Europe Is Fighting the Next Pandemic
Antimicrobial resistance could cause 10 million deaths annually by 2050. Europe is grappling with overuse in healthcare and agriculture. New
Living with Antimicrobial Resistance: A Patient's Story of Powerlessness and Perseverance
Iñaki Morán, a retired delivery company manager from Spain, has faced four bouts of antimicrobial resistance while battling COPD and cancer.
Biosimilars: EU's Cost-Saving Biologics Gain Ground in Healthcare Systems
Biosimilars are biological medicines that are cheaper copies of approved reference drugs, with the same efficacy and safety. The European Co
Medical Interchangeability: How Biosimilars Could Cut EU Healthcare Costs
Medical interchangeability allows patients to switch between a reference biologic drug and its biosimilar, or between different biosimilars,
EU Revamps Health Innovation Rules to Reverse R&D Decline
The EU is losing ground in pharmaceutical innovation, with new drug development falling from 75 to 64 entities between 2011-2022. The Europe
How the EU Can Revitalize Its Pharmaceutical Innovation Pipeline
The EU is falling behind the US and Japan in pharmaceutical innovation. EMA Director General Emer Cooke calls for simpler regulatory pathway